LINC00673 is activated by YY1 and promotes the proliferation of breast cancer cells via the miR-515-5p/MARK4/Hippo signaling pathway - Qiao, Kun; Ning, Shipeng; Wan, Lin; Wu, Hao; Wang, Qin; Zhang, Xingda; Xu, Shouping; Pang, Da (Journal of experimental & clinical cancer research, 2019)
Keywords: Animals; Apoptosis; Binding sites; Breast cancer; Breast Neoplasms - genetics; Breast Neoplasms - metabolism; Breast Neoplasms - pathology; Cancer cells; Cancer research; Cancer therapies; Cell cycle; Cell growth; Cell Line, Tumor; Cell Proliferation; Cellular signal transduction; Chromatin; Development and progression; Diagnosis; Disease-Free Survival; Epigenetic inheritance; Female; Gene expression; Gene Expression Regulation, Neoplastic; Genes; Genetic aspects; Hippo signaling pathway; Hospitals; Humans; LINC00673; Luciferase; MARK4; Metastasis; Mice; Mice, Inbred BALB C; Mice, Nude; MicroRNAs; MicroRNAs - genetics; MicroRNAs - metabolism; Middle Aged; miR-515-5p; Patient outcomes; Protein-Serine-Threonine Kinases - genetics; Protein-Serine-Threonine Kinases - metabolism; RNA; RNA sequencing; RNA, Long Noncoding - genetics; RNA, Long Noncoding - metabolism; Signal Transduction; Tumorigenesis; Tumors; Xenograft Model Antitumor Assays; YY1; YY1 Transcription Factor - metabolism; United States--US; China; Cell proliferation; YY1; Breast cancer; Hippo signaling pathway; LINC00673; MARK4; miR-515-5p